[1] COLLABORATORS G D F. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 [J]. Lancet Public Health, 2022, 7(2): e105-e125. [2] SCHELTENS P, DE STROOPER B, KIVIPELTO M, et al. Alzheimer’s disease [J]. Lancet, 2021, 397(10284): 1577-1590. [3] LIN Y, SHAN P Y, JIANG W J, et al. Subjective cognitive decline: preclinical manifestation of Alzheimer’s disease [J]. Neurol Sci, 2019, 40(1): 41-49. [4] SANFORD A M. Mild cognitive impairment [J]. Clin Geriatr Med, 2017, 33(3): 325-337. [5] KOHLER S, ALLARDYCE J, VERHEY F R, et al. Cognitive decline and dementia risk in older adults with psychotic symptoms: a prospective cohort study [J]. Am J Geriatr Psychiatry, 2013, 21(2): 119-128. [6] 刘翔,房圆,李霞.痴呆前心理行为障碍的临床表现及机制研究进展[J].上海交通大学学报(医学版),2020,40(2):263-266. [7] ISMAIL Z, SMITH E E, GEDA Y, et al. Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment [J]. Alzheimers Dement, 2016, 12(2): 195-202. [8] ISMAIL Z, MCGIRR A, GILL S, et al. Mild behavioral impairment and subjective cognitive decline predict cognitive and functional decline [J]. J Alzheimers Dis, 2021, 80(1): 459-469. [9] ISMAIL Z, AGUERA-ORTIZ L, BRODATY H, et al. The mild behavioral impairment checklist (MBI-C): a rating scale for neuropsychiatric symptoms in pre-dementia populations [J]. J Alzheimers Dis, 2017, 56(3): 929-938. [10] MALLO S C, ISMAIL Z, PEREIRO A X, et al. Assessing mild behavioral impairment with the mild behavioral impairment-checklist in people with mild cognitive impairment [J]. J Alzheimers Dis, 2018, 66(1): 83-95. [11] MALLO S C, ISMAIL Z, PEREIRO A X, et al. Assessing mild behavioral impairment with the mild behavioral impairment checklist in people with subjective cognitive decline [J]. Int Psychogeriatr, 2019, 31(2): 231-239. [12] CUI Y, DAI S, MIAO Z, et al. Reliability and validity of the Chinese version of the mild behavioral impairment checklist for screening for Alzheimer’s disease [J]. J Alzheimers Dis, 2019, 70(3): 747-756. [13] SOO S A, NG K P, WONG F, et al. Mild behaviour impairment checklist (MBI-C): is there a difference in ratings between patient and close informant? [J]. Alzheimer’s & Dementia, 2020, 16(S6): e039239. [14] TARAGANO F E, ALLEGRI R F, HEISECKE S L, et al. Risk of conversion to dementia in a mild behavioral impairment group compared to a psychiatric group and to a mild cognitive impairment group [J]. J Alzheimers Dis, 2018, 62(1): 227-238. [15] MALLO S C, PEREIRO A X, CAMPOS-MAGDALENO M, et al. Neuropsychiatric symptoms in subjective cognitive complaints (SCC) and mild cognitive impairment (MCI): detecting changes over time with the mild behavioral impairment checklist (MBI-C) [J]. Alzheimer’s Dement, 2020, 16(Suppl 6):e041963. [16] MCGIRR A, NATHAN S, GHAHREMANI M, et al. Progression to dementia or reversion to normal cognition in mild cognitive impairment as a function of late-onset neuropsychiatric symptoms [J]. Neurology, 2022, 98(21): e2132-e2139. [17] DIETLIN S, SOTO M, KIYASOVA V, et al. Neuropsychiatric symptoms and risk of progression to Alzheimer’s disease among mild cognitive impairment subjects [J]. J Alzheimers Dis, 2019, 70(1): 25-34. [18] RUTHIRAKUHAN M, ISMAIL Z, HERRMANN N, et al. Mild behavioral impairment is associated with progression to Alzheimer’s disease: a clinicopathological study [J]. Alzheimers Dement, 2022, 18(11): 2199-2208. [19] EBRAHIM I M, GHAHREMANI M, CAMICIOLI R, et al. Effects of race, baseline cognition, and APOE on the association of affective dysregulation with incident dementia: a longitudinal study of dementia-free older adults [J]. J Affect Disord, 2023, 332: 9-18. [20] ACOSTA I, BORGES G, AGUIRRE-HERNANDEZ R, et al. Neuropsychiatric symptoms as risk factors of dementia in a Mexican population: a 10/66 dementia research group study [J]. Alzheimers Dement, 2018, 14(3): 271-279. [21] JACK C R Jr, BENNETT D A, BLENNOW K, et al. NIA-AA research framework: toward a biological definition of Alzheimer’s disease [J]. Alzheimers Dement, 2018, 14(4): 535-562. [22] JOHANSSON M, STOMRUD E, INSEL P S, et al. Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer’s disease [J]. Transl Psychiatry, 2021, 11(1): 76. [23] KARIKARI T K, PASCOAL T A, ASHTON N J, et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer’s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts [J]. Lancet Neurol, 2020, 19(5): 422-433. [24] GHAHREMANI M, WANG M, CHEN H Y, et al. Plasma phosphorylated tau at threonine 181 and neuropsychiatric symptoms in preclinical and prodromal alzheimer disease [J]. Neurology, 2023, 100(7): e683-e693. [25] LI Y, SCHINDLER S E, BOLLINGER J G, et al. Validation of plasma amyloid-β 42/40 for detecting Alzheimer disease amyloid plaques [J]. Neurology, 2022, 98(7): e688-e699. [26] MIAO R, CHEN H Y, GILL S, et al. Plasma beta-amyloid in mild behavioural impairment - neuropsychiatric symptoms on the Alzheimer’s continuum [J]. J Geriatr Psychiatry Neurol, 2022, 35(3): 434-441. [27] NAUDE J P, GILL S, HU S, et al. Plasma neurofilament light: a marker of neurodegeneration in mild behavioral impairment [J]. J Alzheimers Dis, 2020, 76(3): 1017-1027. [28] MATUSKOVA V, ISMAIL Z, NIKOLAI T, et al. Mild behavioral impairment is associated with atrophy of entorhinal cortex and hippocampus in a memory clinic cohort [J]. Front Aging Neurosci, 2021, 13: 643271. [29] IMAI A, MATSUOKA T, NARUMOTO J. Emotional dysregulation in mild behavioral impairment is associated with reduced cortical thickness in the right supramarginal gyrus [J]. J Alzheimers Dis, 2023, 93(2): 521-532. [30] YOON E J, LEE J Y, KWAK S, et al. Mild behavioral impairment linked to progression to Alzheimer’s disease and cortical thinning in amnestic mild cognitive impairment [J]. Front Aging Neurosci, 2022, 14: 1051621. |